Active ingredientLomustineCat. No. P-L087-001CAS 13010-47-4Family · Pharmaceutical analytical standards
Lomustine
An alkylating agent of the nitrosourea family, approved in the United States in 1976 and taken by mouth: it is used mainly against brain tumours and, as a second-line option, in Hodgkin lymphoma. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?Its abbreviation CCNU sums up its chemistry, chloroethyl-cyclohexyl-nitrosourea. It is so fat-soluble that it crosses the blood-brain barrier, and it is also used in veterinary medicine for some tumours in dogs and cats.
Go to the active ingredient →Active ingredientLomustineCat. No. P-L087-001CAS 13010-47-4
Pharmacopoeial impurityLomustine EP Impurity BCat. No. P-L087-002CAS 13908-11-7
Pharmacopoeial impurityLomustine EP Impurity CCat. No. P-L087-003CAS 2387-23-7
Isotopically labelledcis-4'-Hydroxy CCNU Lomustine-d4Cat. No. P-L087-004
Isotopically labelledTrans-4'-Hydroxy CCNU Lomustine-d4Cat. No. P-L087-005
NitrosamineN-Nitroso Lomustine Impurity 1Cat. No. P-L087-006CAS 500545-48-2
NitrosamineN'-Nitroso Lomustine EP Impurity BCat. No. P-L087-007CAS 54749-91-6
Metabolitecis-4'-Hydroxy CCNU LomustineCat. No. P-L087-008CAS 52049-26-0
ImpurityLomustine Impurity 1Cat. No. P-L087-009CAS 1222864-16-5
Metabolitetrans-4'-Hydroxy CCNU LomustineCat. No. P-L087-010CAS 56239-24-8
Pharmacopoeial impurityLomustine EP Impurity ACat. No. P-L087-011CAS 2214-72-4No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceLomustine CRSEDQM code L0745000Family LomustineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.